203 related articles for article (PubMed ID: 4611949)
1. [Endocrine ophthalmopathy].
Pickardt CR; Boergen KP; Heinze HG
Internist (Berl); 1974 Oct; 15(10):497-505. PubMed ID: 4611949
[No Abstract] [Full Text] [Related]
2. [Treatment of endocrine ophthalmopathy].
Raith L
Z Allgemeinmed; 1973 Dec; 49(35):1727-30. PubMed ID: 4131142
[No Abstract] [Full Text] [Related]
3. [Long-acting thyroid stimulator (L.A.T.S.) and its place in the physiopathogeny of Basedowian hyperthyroidism].
Guéritée N
Rev Fr Endocrinol Clin; 1968; 9(4):351-66. PubMed ID: 5755332
[No Abstract] [Full Text] [Related]
4. [Endocrine ophthalmopathy].
Studer H
Ophthalmologica; 1969; 158(5):565-77. PubMed ID: 5394539
[No Abstract] [Full Text] [Related]
5. [Endocrinal ophthalmopathy].
Bouzas A
Minerva Oftalmol; 1971; 13(2):69-75. PubMed ID: 5171907
[No Abstract] [Full Text] [Related]
6. [Endocrine exophthalmos].
Lavergne G; Winand R
Bull Soc Belge Ophtalmol; 1973; 163(1):1-170. PubMed ID: 4351085
[No Abstract] [Full Text] [Related]
7. Large doses of radioiodide in Graves' disease: effect on ophthalmopathy and long-acting thyroid stimulator.
Pequegnat EP; Mayberry WE; McConahey WM; Wyse EP
Mayo Clin Proc; 1967 Dec; 42(12):802-11. PubMed ID: 4169552
[No Abstract] [Full Text] [Related]
8. [Graves-Basedow type ophthalmopathy and primary hypothyroidism].
Cathelineau G; Fribourg-Desi M
Nouv Presse Med; 1974 Sep; 3(32):1995-8. PubMed ID: 4372586
[No Abstract] [Full Text] [Related]
9. Pathogenesis of Graves' ophthalmopathy.
Gorman CA; Bahn RS
Dev Ophthalmol; 1989; 20():1-7. PubMed ID: 2687045
[No Abstract] [Full Text] [Related]
10. [Treatment of endocrine ophthalmopathy].
Schneider C
Fortschr Med; 1974 Aug; 92(22):950-2. PubMed ID: 4411341
[No Abstract] [Full Text] [Related]
11. [New ideas on the regulation of thyroid function by LATS (long-acting thyroid stimulator) and their repercussion on human pathology].
Strumia E
Minerva Med; 1967 Nov; 58(90):3879-85. PubMed ID: 5630606
[No Abstract] [Full Text] [Related]
12. Advances in the treatment of endocrine disorders.
Hall R
Practitioner; 1969 Oct; 203(216):494-500. PubMed ID: 4311092
[No Abstract] [Full Text] [Related]
13. Thyroid eye disease and its relationship to the long-acting thyroid stimulator.
Hollows FC; Beaumont P
Trans Aust Coll Ophthalmol; 1969; 1():37-44. PubMed ID: 4250318
[No Abstract] [Full Text] [Related]
14. [Endocrine ophthalmopathy from the viewpoint of the opthalmologist].
Broschmann D
Zentralbl Chir; 1965; 90(26):1278-80. PubMed ID: 5899069
[No Abstract] [Full Text] [Related]
15. LATS activity, hyperthyroidism, exophthalmos, pretibial myxoedema and acropachy.
Bartholomew C
Br J Clin Pract; 1972 Sep; 26(9):431-3. PubMed ID: 5080337
[No Abstract] [Full Text] [Related]
16. [Basdowian ophthalmic diseases. Pathogenic role of L-triiodothyronine and of LATS. Therapeutic role of L-thyroxine, of d-thyroxine and of corticoids].
Mahaux JE; Nagel M
Brux Med; 1967 Oct; 47(43):1003-16. PubMed ID: 4193087
[No Abstract] [Full Text] [Related]
17. [Etiology of Basedow's disease, with special reference to LATS].
Nagata K
Naika Hokan; 1969 Jul; 16(7):297-317. PubMed ID: 4901097
[No Abstract] [Full Text] [Related]
18. The role of long-acting thyroid stimulator and of thyroid autoimmunity in the pathogenesis of euthyroid endocrine ophthalmopathy.
Földes J; Takó J; Bános C; Gesztesi E
Acta Med Acad Sci Hung; 1971; 28(2):171-9. PubMed ID: 5172524
[No Abstract] [Full Text] [Related]
19. Endocrine exophthalmos.
Havard CW
Br Med J; 1972 Feb; 1(5796):360-3. PubMed ID: 4550413
[No Abstract] [Full Text] [Related]
20. LATS and Graves' disease.
Soloman DH; Chopra IJ
Calif Med; 1970 Aug; 113(2):50-5. PubMed ID: 5538194
[No Abstract] [Full Text] [Related]
[Next] [New Search]
